Abanto, Junerlyn G.

HRN: 14-22-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2024
CEFTRIAXONE 1G (VIAL)
11/23/2024
11/29/2024
IV
2 Grams
OD
Uti
Waiting Final Action 
11/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/26/2024
12/02/2024
IV
4.5g
Q8h
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: